LUPIN
Live / Registered — Registered and renewed (as of 12 Mar 2026)
What this means for you
Registered since 22 Dec 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Dec 2025).
Record
- Serial number
- 77766816
- Registration number
- 4874579
- Mark type
- Design + words
- Filed
- 24 Jun 2009
- Published for opposition
- 28 Feb 2012
- Registered
- 22 Dec 2015
- Next maintenance due
- 22 Dec 2025
- Attorney of record
- Robert L. Powley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious and parasitic diseases; antibiotics; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine and metabolic systems; pharmaceutical preparations for the treatment of mental and behavioral conditions and disorders; antidepressants; pharmaceutical preparations for the treatment of diseases and disorders of the nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the eye and adnexa; pharmaceutical preparations for the treatment of diseases and disorders of the ear and mastoid process; pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system; antihypertensives; pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system; pharmaceutical preparations for the treatment of diseases and disorders of the digestive system; pharmaceutical preparations for the treatment of diseases and disorders of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal system and connective tissue; pharmaceutical preparations for the treatment of diseases and conditions of the genitourinary system; and pharmaceutical preparations for the treatment of diseases and disorders associated with pregnancy, childbirth and the peurperium, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Owner
- Lupin Pharmaceuticals, Inc., Naples, FL, US
- Lupin Pharmaceuticals, Inc., Baltimore, MD, US
- Lupin Pharmaceuticals, Inc., Baltimore, MD, US
Prosecution history
- 12 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 Mar 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 Mar 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 12 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Dec 2025 — TEAS SECTION 8 & 9 RECEIVED
- 22 Dec 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 30 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Oct 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Jul 2021 — TEAS SECTION 8 & 15 RECEIVED
- 22 Dec 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Dec 2015 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Nov 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Nov 2015 — DATA MODIFICATION COMPLETED